A U.K. research group has launched what they say is the first ever randomized clinical trial conducted with the objective of preventing the onset of chronic widespread pain (CWP -- the characteristic feature of fibromyalgia). Led by Clinical Professor of Epidemiology and department Chair Gary J. Macfarlane and Study Coordinator Marcus Beasley of the Epidemiology Group at the University of Aberdeen School of Medicine Institute of Applied Health Sciences School of Medicine and Dentistry in Aberdeen, UK, the research team, which includes investigators from other U. Aberdeen departments, the University of Huddersfield , at Huddersfield, UK, Keele University , at Keele, UK, and the University of Manchester , Manchester, UK, will recruit persons at high risk of developing CWP and they will be randomly allocated to receive either usual care or eight sessions of Cognitive Behaviour Therapy (CBT) delivered by telephone. Potentially eligible subjects will be identified through a large-scale population survey.